BioPharma Dive ٢٤ مارس ٢٠٢٦ Gilead, with Ouro deal, wagers $1.7B on bispecifics for autoimmune diseases
BioPharma Dive ٢٤ مارس ٢٠٢٦ How former Acorda CEO Ron Cohen landed at a Parkinson’s cell therapy startup
BioPharma Dive ٢٣ مارس ٢٠٢٦ Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
BioPharma Dive ٢٣ مارس ٢٠٢٦ FDA seeks feedback on voucher program; Study data lift ‘overhang’ on Insmed shares